Legal

Errors in Experimental Treatment Prescriptions

March 8, 2024
4 min read
Errors in Experimental Treatment Prescriptions

Errors in Experimental Treatment Prescriptions: Legal Keys and Medical Protocol

Introduction

Experimental medicine is essential for therapeutic advancement, but as it involves more uncertainties and risks, it requires strict adherence to ethical and legal protocols. Errors in prescribing experimental treatments can lead to devastating consequences and complex legal processes for medical negligence. This text, updated for 2024 and supported by recent doctrine, aims to offer the most comprehensive reference for professionals and those affected.


What are experimental treatments?

Experimental treatments are those whose efficacy and safety are still under evaluation, usually administered through clinical trials or under “compassionate use.” Their application requires rigorous evaluation, ethical supervision, and generally the authorization of health authorities (e.g., Spanish Agency of Medicines and Medical Devices, EMA, or FDA).


Common errors in their prescription

1. Deficiencies in informed consent

Informed consent, regulated with particular emphasis in experimental treatments, is more than just a formality: it is a fundamental right of the patient to decide, based on real and understandable information about:

  • Nature and experimental phase.
  • Benefits, risks, and alternatives.
  • Rights during the trial (voluntary withdrawal, access to information, complaints).

Recent jurisprudence (Spain, 2023-2024) emphasizes that omission or defect in informed consent constitutes a violation of the patient's rights and can lead to convictions for moral and material damages.

2. Errors in patient selection and protocol

In 2024, guidelines emphasize that non-compliance with inclusion/exclusion criteria or any unjustified deviation from protocol can have irreversible consequences for the patient and the validity of the treatment. Documented real cases highlight patients improperly included in trials or receiving inadequate doses due to failures in interpreting clinical criteria.

3. Lack of traceability and clinical documentation

Notification and safety systems, such as SiNASP in Spain, have detected multiple incidents related to:

  • Omission of adverse effects registration.
  • Lack of updates in the clinical history.
  • Failure to communicate serious incidents to ethics committees or competent authorities.

4. Non-compliance with “lex artis medica”

Applying experimental treatments without the support of lex artis (accepted medical performance standards) constitutes serious negligence. In the experimental context, even greater rigor is required: strict compliance with approved protocols, continuous supervision, and reporting.


Legal responsibility: What recent jurisprudence says

Legislative evolution (including GDPR in data protection) and recent rulings in Spain have consolidated key criteria:

  • Informed consent: Without it, the administration of experimental treatments constitutes negligence and may involve compensations, administrative sanctions, and, in severe cases, criminal responsibility.
  • Documentation and communication: Courts consider it objective responsibility to omit records or reports, as well as to hide adverse effects.
  • Lex artis: Deviating from recognized standards, even due to business or industry pressures, does not exempt from responsibility.

Preventing prescription errors

1. Continuous training: Training in regulations, clinical trials, and informed consent.

2. Protocols and auditing: Implement periodic internal reviews; cooperate with ethics committees.

3. Transparency with the patient: Use clear and updated language, provide understandable documentation, and encourage two-way communication.

4. Notification and traceability: Use standardized notification systems for all relevant events.


Conclusion

The current legal and ethical framework leaves no room for improvisation in the administration of experimental treatments. Preventing errors involves scrupulous compliance with lex artis, obtaining specific informed consent, and maximum transparency and traceability. Errors in this area are especially monitored and sanctioned, and being informed is key for both professionals and patients.


Your inquiry or case may require personalized legal advice. If you need help, contact a specialist lawyer in medical negligence.

Share article

Need Guidance on Your Case?

We are here to listen to you. Tell us your situation and we will give you an honest assessment, without obligation.